Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

32results about How to "Rapid dissolution" patented technology

Melogabalin besylate tablet containing excellent stabilizer and preparation method of melogabalin besylate tablet

The invention discloses an oral solid preparation melogabalin besylate tablet containing an excellent stabilizer and a preparation method thereof. A tablet core contains but is not limited to melogabalin besylate, one or two or more filling agents, one or two or more disintegrating agents, one or two or more flow aids and various stabilizer compositions. According to the invention, the optimal stabilizer composition is selected through investigation, so that the growth of main degradation impurities and oxidation impurities is effectively controlled, the product stability is improved, and the tablets with stable quality are obtained. The product is rapidly dissolved out, the dissolution uniformity is good, the intermediate tabletting is smooth, the compressibility is good, and the prepared finished product is good in appearance, free of small holes and stable and controllable in quality.
Owner:JIANGSU ALICORN PHARMATECH CO LTD

Preparation process of micromolecular cubilose peptide and compound tablet thereof

The invention provides a preparation process of micromolecular cubilose peptide and a compound tablet thereof, and belongs to the technical field of protein and peptide. The preparation process of the micromolecular cubilose peptide comprises the following steps: freezing and crushing cubilose; and carrying out compound enzyme enzymolysis. The preparation method comprises the following steps: repeatedly freezing and crushing cubilose to prepare cubilose powder, adding the cubilose powder into deionized water, heating and stewing, and adding a compound enzyme formed by mixing neutral protease and flavourzyme for ultrasonic-assisted enzymolysis to obtain the micromolecular cubilose peptide, when the neutral protease and the flavourzyme are mixed according to the mass ratio of 1: (2.8-3.4) to conduct enzymolysis on the cubilose, hydrolysis can be conducted from multiple positions, smaller peptide fragments are formed, the hydrolysis degree is effectively improved, sialic acid originally combined with protein is also released along with hydrolysis of the protein, and therefore the content of sialic acid in the cubilose is increased. Therefore, the content of sialic acid in the prepared micromolecular cubilose peptide can be effectively improved.
Owner:SHANDONG LONGBEI BIOTECHNOLOGY CO LTD +1

Lcidipine film-controlled sustained-release pellet capsule and preparation method thereof

The invention discloses a lacidipine film-controlled sustained-release pellet capsule and a preparation method thereof, relates to the technical field of medicines, and aims to solve the problem of release reduction caused by film aging of a lacidipine film-controlled sustained-release pellet prepared by an aqueous dispersion coating. The preparation method comprises the following steps: respectively weighing a lacidipine bulk drug, a polymer carrier material and a plasticizer according to a prescription amount, grinding and uniformly mixing to prepare the lacidipine solid dispersion. A sustained-release coating film of the pellet capsule contains Eurdragit RL30D, a plasticizer triethyl citrate and an anti-sticking agent talcum powder, and a pellet core contains croscarmellose sodium and an excipient. According to the lacidipine solid dispersion solid preparation provided by the invention, lacidipine exists in the carrier material in a microcrystalline state, an amorphous state, a colloidal dispersion state or a molecular dispersion state, so that the lacidipine solid dispersion solid preparation has high dispersity, the dissolution speed of a medicine is accelerated, the absorption of the medicine can be promoted, and the bioavailability is improved.
Owner:HARBIN PHARMA GROUP TECH CENT

Berberine tannate oral preparation and preparation method thereof

The invention belongs to the technical field of medicines, and relates to a berberine tannate oral preparation and a preparation method thereof. The oral preparation comprises berberine tannate, a filling agent, a disintegrating agent, an adhesive and a wetting agent, the filling agent is pregelatinized starch, microcrystalline cellulose and colloidal silicon dioxide; the disintegrating agent is one or more of sodium carboxymethyl starch, cross-linked sodium carboxymethyl cellulose and cross-linked polyvinylpyrrolidone. The auxiliary materials of the berberine tannate oral preparation cooperate with one another, so that the flowability and compressibility of the powder are effectively improved, and the obtained final preparation product is excellent in stability and dissolution property and high in bioavailability; in addition, the oral preparation is simple in preparation process and suitable for large-scale production.
Owner:GUANGZHOU BOJI MEDICINE SERVICES

Metronidazole particles, preparation containing metronidazole particles and preparation method

PendingCN121987585ARapid dissolutionDoes not affect bioavailabilityOrganic active ingredientsAntibacterial agentsCellulosePharmacy medicine
The invention discloses metronidazole particles, a preparation containing the metronidazole particles and a preparation method of the metronidazole particles. The metronidazole particle comprises a drug core and a coating layer, wherein the coating layer is coated on the outer surface of the drug core; the medicine core comprises metronidazole; the coating layer comprises a film-forming material, and the film-forming material comprises gastric-soluble acrylic resin and ethyl cellulose. The metronidazole granule has low dissolution rate in water and a medium with high pH (such as pH 6.8), especially the dissolution rate in 15 minutes is less than or equal to 10%, the dissolution rate at low pH (such as pH 1.2-4.5) is consistent with the dissolution rate of commercially available tablets, and the metronidazole granule is rapidly dissolved out.
Owner:SHANGHAI WHITTILONG PHARMACEUTICAL LTD +1

A ceramic-like antibacterial flame-retardant composition with inhibition of black spot generation

PendingCN122587351ANo antibacterial effectRapid dissolution
This invention discloses a white, high-gloss, antibacterial, and flame-retardant composition that inhibits the formation of black spots. It comprises 19.85-22.8 parts by weight of propylene homopolymer A, 30-40 parts by weight of propylene block copolymer B, 8-15 parts by weight of bromobisphenol S derivative flame retardant C, 5-10 parts of synergistic flame retardant D, 15-30 parts of coated zinc oxide E1, 15-30 parts of coated barium salt, and 0.15-1 part of additive F. It is particularly important to note that the additive does not contain organic phosphite antioxidants, inorganic hypophosphite additives, thioester additives, or carbonate additives. This composition achieves a UL94 1.6mm V0 flame retardant rating, while parts made from it have an excellent ceramic-like gloss (60° gloss ≥80%). Surprisingly, without the addition of additional antibacterial agents, the composition itself has an antibacterial efficiency of over 90% against Escherichia coli and imported Staphylococcus aureus. With the addition of additional antibacterial agents, the antibacterial effect against both of these bacteria exceeds 99%. In addition, the number of black spots generated during the preparation process is significantly reduced.
Owner:固合工程材料(江苏)有限公司

Veterinary albendazole tablet and preparation method thereof

The invention belongs to the technical field of veterinary drugs, relates to a veterinary albendazole tablet, and provides a preparation method of the preparation. The tablet consists of albendazole, trehalose, sodium taurocholate and other pharmaceutically acceptable adhesives, disintegrating agents and lubricating agents. The albendazole is fully dispersed by spray-drying a mixed solution of albendazole, trehalose and sodium taurocholate, and the dosage of trehalose and sodium taurocholate is controlled, so that the dissolution and stability of the product are improved.
Owner:LINYI JINCUI VETERINARY MEDICINES CO LTD

Pentaethylenehexamine-beta-cyclodextrin grafted folic acid-included cannabidiol nanospheres, methods of preparation and uses

The application provides a pentaethylenehexamine-beta-cyclodextrin grafted folic acid inclusion cannabidiol nanosphere, a preparation method and an application, the method first prepares a pentaethylenehexamine-beta-cyclodextrin grafted folic acid (PEHA-beta-CD-FA) targeting carrier, then cannabidiol (CBD) is mixed with the carrier in an ethanol-water mixed solvent in a certain proportion, a stable inclusion system is formed through ultrasonic-assisted inclusion + room-temperature light-avoiding stirring, and the system is purified through dialysis, freeze-drying or spray-drying, so that the spherical nanoparticles with uniform particle size of about 100 nm are obtained. The application solves the problems that CBD has extremely low water solubility, poor bioavailability and lacks targeted delivery, the obtained nanospheres have folic acid receptor active targeting, pH response drug release, high encapsulation rate and high colloidal stability, can significantly improve the solubility, dissolution rate and in-vivo targeted delivery efficiency of CBD, and are suitable for the fields of anti-inflammatory, neuroprotective and the like drugs, cosmetics and functional foods.
Owner:YUNNAN UNIV +1

Sitaπb and metformin extended release pharmaceutical composition, and preparation method and application thereof

The application provides a sitagliptin and metformin hydrochloride sustained-release pharmaceutical composition and a preparation method and application thereof, and relates to the technical field of sustained-release preparations. The pharmaceutical composition comprises a sustained-release tablet core and a quick-release coating layer; the sustained-release tablet core comprises active ingredients metformin hydrochloride and a sustained-release matrix material hydroxypropyl methyl cellulose, and the sustained-release tablet core does not contain microcrystalline cellulose; the quick-release coating layer comprises active ingredients sitagliptin phosphate; the weight ratio of metformin hydrochloride to hydroxypropyl methyl cellulose in the sustained-release tablet core is 50:(24-27). The composition realizes double-phase release of drugs by using a double-layer structure; by removing the microcrystalline cellulose and limiting the specific ratio of active ingredients to the matrix material, the forming property of the preparation and the ideal dissolution behavior are ensured while the tablet weight is significantly reduced to improve the swallowing compliance, and the technical problem that a high drug loading compound preparation is difficult to maintain the function of the sustained-release matrix under a large amount of weight reduction is successfully solved.
Owner:BEIJING JINGFENG PHARMA GRP +2

Pinefibrate oral dissolving film agent and preparation method thereof

The invention relates to the technical field of medicine preparation, in particular to a baltefibrate oral-soluble film agent and a preparation method thereof, and the baltefibrate oral-soluble film agent can achieve ideal dissolution speed and bioavailability equivalent to tablets in an oral cavity by controlling particle size distribution of raw material medicines in the baltefibrate oral-soluble film agent and dissolving baltefibrate through polyvinylpyrrolidone aqueous dispersion. According to the invention, the characteristic of good dissolution effect can be realized without additionally adding a pH regulator, and rapid disintegration and dissolution can be realized without additionally adding water in the oral cavity. The preparation method of the Pengfibrate oral soluble film is simple and easy to operate, and is suitable for modern industrial mass production, required production equipment is conventional equipment, the cost is saved, and the production possibility is improved.
Owner:HARBIN PHARMA GROUP TECH CENT

A formulation comprising ezetimibe and atorvastatin calcium and a method for preparing the same

ActiveCN117243910BDoes not promote degradationreduce exposure
The present application belongs to the technical field of pharmaceutical preparations, and relates to a combined preparation of ezetimibe and atorvastatin calcium, in particular to a preparation containing ezetimibe and atorvastatin calcium and a preparation method thereof. A double-layer tablet is formed by an ezetimibe layer and an atorvastatin calcium layer, the ezetimibe layer is composed of ezetimibe and a first excipient, and the atorvastatin calcium layer is composed of atorvastatin calcium and a second excipient; the second excipient does not contain an alkaline stabilizer, and kaolin is used as a filler in the second excipient. By adding kaolin as a filler, the present application can not only avoid the addition of an alkaline adjusting agent, but also improve the stability of ezetimibe and atorvastatin calcium.
Owner:SHANDONG CHUANGXIN PHARMA RES & DEV

Celecoxib solid dispersion with solubilizing property and high drug loading capacity and preparation method of celecoxib solid dispersion

The invention discloses a high-drug-loading-capacity celecoxib solid dispersion with solubilizing performance and a preparation method thereof. The solid dispersion is prepared from the following components in percentage by mass: 50% of celecoxib, 40-47% of a carrier material and 3-10% of a crystal inhibitor, the total percentage of all the components is 100%. Wherein the carrier material is polyacrylic resin; the crystal inhibitor is selected from one or more of copovidone VA64, povidone K30, hydroxypropyl methylcellulose E5 and hydroxypropyl methylcellulose E50; the solid dispersion provided by the invention has high dissolution rate and good stability, and can effectively inhibit recrystallization of a drug in a supersaturated solution and maintain the supersaturation degree of the drug in the solution; according to the present invention, the carrier-crystal inhibitor binary polymer combination is adopted to achieve the complete release of the drug, and the new idea is provided for the preparation or the process innovation of the high drug loading capacity celecoxib preparation.
Owner:ZHEJIANG UNIV OF TECH

White carbon black, its preparation method and application

ActiveCN121894667BRapid dissolutionhigh purity
The application discloses white carbon black and a preparation method and application thereof, and the preparation method comprises the following steps: S1, silicon source pretreatment: mixing rice husk ash and a sodium hydroxide solution, reacting under the assistance of microwaves, adding a composite impurity removing agent for deep purification after filtration, and obtaining refined water glass solution; S2, modified precursor preparation: adding a composite modifier into the refined water glass solution, and obtaining a modified precursor solution; S3, high-pressure spray carbonization: atomizing the precursor solution, and reacting with mixed gas of CO2 and N2 in a high-pressure spray reaction tower to generate white carbon black slurry; S4, post-treatment: after washing and grinding, the white carbon black slurry is spray dried to obtain a finished product; and S5, waste liquid circulation: reacting the washing waste liquid with limestone, and recycling the alkali liquor for the step S1. The application realizes the recycling of waste resources; the product has high activation degree and excellent dispersibility, is applied to rubber reinforcement, improves processing performance, significantly enhances mechanical properties such as tensile strength, and has a good industrial application prospect.
Owner:SHAANXI SECROSI ECOLOGICAL BUILDING MATERIALS CO LTD

Lycium barbarum polysaccharide chewable tablet for relieving chronic fatigue syndrome

The present invention relates to the technical field of Chinese medicine preparations, and in particular to a wolfberry polysaccharide chewable tablet for relieving chronic fatigue syndrome. In terms of mass percentage, the raw materials of the wolfberry polysaccharide chewable tablet for relieving chronic fatigue syndrome include 20-30% wolfberry polysaccharide and the remainder of pharmaceutically acceptable excipients. The present invention also provides the use of wolfberry polysaccharide in the preparation of a drug for relieving chronic fatigue syndrome. The wolfberry polysaccharide chewable tablet of the present invention has a sweet and sour taste, is easy to take and carry, does not require water to take, does not require disintegration, has a fast absorption rate, and has a fast drug dissolution, and is more suitable for children, the elderly and patients with dysphagia. The wolfberry polysaccharide chewable tablet of the present invention has a strong efficacy, can be directly used to relieve chronic fatigue syndrome, and greatly improves bioavailability. The present invention finds that wolfberry polysaccharide has the effect of relieving chronic fatigue syndrome, develops a new use of wolfberry polysaccharide, and improves the utilization value of wolfberry polysaccharide.
Owner:QINGHAI TIANJING HERBAL BIOTECHNOLOGY CO LTD

Preparation method of super-fine creatine with improved solubility and absorption efficiency

PendingCN122536736AReduce risk of conversionImprove dispersion uniformity
This invention belongs to the field of sports nutrition supplements and food ingredient processing technology, and particularly relates to a method for preparing ultrafine creatine with improved solubility and absorption efficiency. Creatine monohydrate is pretreated with low water activity and then ultrafinely pulverized using a low-temperature airflow. Malic acid and citric acid are then enriched and coated onto the surface of the creatine particles under low water activity conditions. The particles are then granulated at low temperature to form porous secondary composite microparticles. These composite microparticles maintain a high crystal form retention rate of creatine monohydrate and a low creatinine production rate in their dry powder state. Upon reconstitution with water, they rapidly disintegrate and form a locally acidic interface environment, improving the wetting, dispersibility, and dissolution efficiency of creatine.
Owner:JILIN HENGMEI YUCHUANG HEALTH TECH CO LTD +1

Maca compound fermentation composition as well as preparation method and product thereof and application of maca compound fermentation composition in fatigue resistance

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a maca compound fermentation composition, a preparation method and a product thereof, and an application of the maca compound fermentation composition in fatigue resistance. The maca compound fermentation composition provided by the invention is prepared from 15-25 parts of maca, 1-3 parts of pine pollen and 15-20 parts of rhizoma polygonati through probiotic fermentation. The maca compound fermentation composition provided by the invention is rich in active ingredient polysaccharide in maca, and has a good anti-fatigue effect. According to the maca compound fermentation composition provided by the invention, the inherent spicy taste of maca and the sweet taste of the rhizoma polygonati raw material are effectively reduced, aromatic compounds and volatile flavor substances related to oxidation are enriched, and the taste of the product is improved.
Owner:GUOZHEN HEALTH TECH (BEIJING) CO LTD

Maca compound fermentation composition, preparation method and product thereof, and application of maca compound fermentation composition in improving sexual function

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a maca compound fermentation composition, a preparation method and a product thereof, and application of the maca compound fermentation composition in improving sexual function. The maca compound fermentation composition is prepared from maca, pine pollen, fructus lycii and lactobacillus plantarum. According to the preparation method disclosed by the invention, the maca compound fermented composition is obtained by fermenting maca, pollen pini and fructus lycii through lactobacillus plantarum. The maca compound fermentation composition provided by the invention has higher biological activity and has great superiority in the aspect of improving sexual function. The maca compound fermentation composition provided by the invention also has an excellent taste which is easy to accept, and beneficial groups are easier to expand.
Owner:GUOZHEN HEALTH TECH (BEIJING) CO LTD

A fast-dissolving cariprazine hydrochloride orodispersible film preparation and preparation method thereof

The present invention provides a fast-dissolving cariprazine hydrochloride oral dissolving film preparation and a preparation method thereof, and relates to the field of medical technology. The cariprazine hydrochloride oral dissolving film preparation comprises components according to mass fraction: 1%-10% active ingredient, 20%-80% film-forming material, 5%-50% disintegrant, 2%-27% plasticizer and 0.3%-3% other auxiliary material components; the active ingredient is cariprazine hydrochloride, and the particle size range is D90=40μm-95μm; the film-forming material is a mixture of hydroxypropyl methylcellulose and hydroxypropyl cellulose, or polyoxyethylene; the disintegrant is selected from one or more of mannitol, lactose, and sodium chloride; the plasticizer is selected from one or more of polyethylene glycol 400, glycerol, propylene glycol, silicone oil, polypropylene glycol, hexylene glycol, and water. The cariprazine hydrochloride oral dissolving film preparation of the present invention has high dissolution performance and high mechanical properties.
Owner:HQ PHARMA (SHANDONG) CO LTD +1

Tilgorazan amorphous solid dispersion, tigorazan-containing tablet core, tigorazan tablet and preparation process of tigorazan amorphous solid dispersion

The invention discloses a tigorazan amorphous solid dispersion, a tigorazan-containing tablet core, a tigorazan tablet and a preparation process of the tigorazan amorphous solid dispersion. The invention specifically discloses a tigorasan solid dispersion. The tigorasan solid dispersion comprises tigorasan and a carrier, the tigorasan is one or more of a tigorasan A crystal form, a tigorasan B crystal form and a tigorasan amorphous form; the carrier comprises copovidone and polyethylene glycol; the mass ratio of the copovidone to the polyethylene glycol is 1: (0.5-2). The invention also provides a preparation method of the tigorazan solid dispersion, a tigorazan-containing tablet core and a preparation method thereof, and a tigorazan tablet and a preparation method thereof. According to the method disclosed by the invention, wet granulation is adopted, so that the preparation process is simpler, the product quality is easier to control, the production efficiency is improved, large-scale production is facilitated, and the prepared tigoraz tablets are good in content uniformity and good in stability.
Owner:SHANDONG LUOXIN PHARMA GRP CO LTD +3

Radix tetrastigme powder for treating hand-foot-and-mouth disease and composition of radix tetrastigme powder

PendingCN119055713ARetained effectquick effectPowder deliveryAntiviralsHand foot mouth diseaseSpray dried
The invention belongs to the technical field of traditional Chinese medicine application and preparation, and provides radix tetrastigme powder for treating hand-foot-and-mouth disease and a composition of the radix tetrastigme powder. The preparation method comprises the following steps: cutting newly collected radix tetrastigme root tubers into thick slices, carrying out superfine grinding treatment on the thick slices, and carrying out spray drying to obtain the radix tetrastigme wall-broken powder. The radix tetrastigme wall-broken powder can be used for preventing and treating the hand-foot-and-mouth disease and is good in safety and few in side effect, and the medical application of radix tetrastigme is expanded.
Owner:JINAN SUNNYPHARMACY

Salt of 3, 4-dihydroisoquinoline compound as well as preparation method and application thereof

The invention provides hippurate of a compound as shown in a formula (A), a solid form, a crystal form and a specific crystal form of the hippurate, a pharmaceutical composition containing the hippurate and application of the hippurate. The hippurate of the compound shown in the formula (A) has the characteristics of good solubility, low hygroscopicity, good stability and the like, and is suitable for being used as a raw material medicine. # imgabs0 #
Owner:CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO LTD

Quick-absorption frovatriptan succinate tablet and preparation method thereof

InactiveCN119499195ARapid dissolutionDissolution stabilityOrganic active ingredientsNervous disorderPharmacy medicinePharmaceutical drug
The invention discloses a quick-absorption frovatriptan succinate tablet and a preparation method thereof. In raw materials for preparing the quick-absorption frovatriptan succinate tablet, auxiliary materials comprise lactose and mannitol, and preferably, the weight ratio of the lactose to the mannitol is (3-5): 1. The frovatriptan succinate tablet capable of being rapidly absorbed is high in dissolution speed, stable in dissolution and capable of rapidly releasing drugs in vivo and accelerating drug absorption, so that the onset time of the drugs is shortened. And more medicines can be absorbed to enter blood circulation, so that the bioavailability of the medicines is increased, and the treatment effect is improved.
Owner:QINGDAO CONSON PHARMACEUTICAL CO LTD

Liquid medicine extraction device

The utility model relates to the technical field of liquid medicine processing, and discloses a liquid medicine extraction device which comprises an extraction mechanism, the extraction mechanism comprises a dipping tank, a mounting hole is formed in the center of the inner bottom wall of the dipping tank, and the front end and the rear end of the inner bottom wall of the dipping tank are each provided with a discharging hole. And a filter separator is fixedly mounted on the outer bottom wall of the impregnating tank and located at the openings of the two discharge holes. The efficient stirring mechanism is arranged in the dipping tank, namely, the stirring paddle is arranged in the dipping tank, the multiple layers of stirring blades are arranged on the outer side of the stirring paddle, and the stirring blades are driven by the motor to stir medicinal materials and solvents at different heights, so that uniform mixing is ensured; the shape and the rotating speed of the stirring blades can be optimally designed according to the size of the dipping tank and the characteristics of medicinal materials.
Owner:SHANDONG UNOVET PHARM CO LTD

Integrally-formed heat-not-burn smoke cartridge and preparation method thereof

The invention provides a preparation method of an integrally formed heat-not-burn cigarette cartridge, which comprises the following steps: A) mixing and forming a tobacco raw material, an adhesive, water and perfume, and freeze-drying to obtain a porous tobacco incense stick inner core; and B) stirring and mixing a tobacco raw material, an adhesive, a reinforcing agent and a humectant, pouring the mixture into a mold containing the porous tobacco incense stick inner core, and freeze-drying to obtain the integrally-formed heat-not-burn cigarette cartridge. The smoke cartridge prepared from the tobacco raw materials and the additives through a freeze drying method contains rich three-dimensional porous honeycomb structures and has the advantages of being large in specific surface area, high in porosity, small in density and the like, a gas path is formed, smoke and aroma components can be rapidly dissolved out and released easily, the suction resistance is reduced, and the user experience is better. The porosity of the internal passage structure of the three-dimensional porous smoke cartridge can be adjusted through the solid content of the raw materials. And the integrally-formed smoke cartridge prepared by the process is better in uniformity, and the stability of the product can be remarkably improved.
Owner:HUBEI CHINA TOBACCO INDUSTRY CO LTD +1

Valaciclovir hydrochloride tablet and preparation method thereof

The invention provides a valaciclovir hydrochloride tablet and a preparation method thereof, and the valaciclovir hydrochloride tablet comprises the following raw materials in parts by weight: 110 to 150 parts of valaciclovir hydrochloride, 15 to 20 parts of a polyaspartic acid-glutathione cross-linked compound, 10 to 15 parts of cross-linked povidone XL-10, 8 to 10 parts of colloidal silicon dioxide, 10 to 15 parts of microcrystalline cellulose 101 and 5 to 8 parts of magnesium stearate. And 10-13 parts of a medicinal film coating premix. The valaciclovir hydrochloride tablet disclosed by the invention is short in disintegration time, can be quickly dissolved out, almost realizes complete dissolution within 15 minutes, and reduces the impurity contents of acyclovir and guanine. The stability is good, the accelerated stability dissolution does not have the tendency of slowing down, the production process is simple, and the requirements of large-scale production are met. The valaciclovir hydrochloride is coated in a polyaspartic acid-glutathione cross-linked compound, so that the influence of excessive moisture on the crystal form of the valaciclovir hydrochloride is avoided, the moisture of particles is controlled, the hydrolysis of the valaciclovir hydrochloride is limited to the greatest extent, and the stability of the valaciclovir hydrochloride is improved.
Owner:HAINAN BRIGHT FUTURE PHARMA

Empagliflozin pharmaceutical composition and preparation method thereof

The invention provides an empagliflozin pharmaceutical composition and a preparation method thereof, the empagliflozin pharmaceutical composition comprises empagliflozin and pharmaceutically acceptable auxiliary materials, and by screening specific auxiliary materials, especially the proportion of microcrystalline cellulose to mannitol, the prepared pharmaceutical composition can realize high dissolution and has better stability.
Owner:JIANGSU HANSOH PHARMA CO LTD +1

Efficient resourceful treatment method for waste residues of fireworks and firecrackers

The invention discloses an efficient resourceful treatment method of firework and firecracker waste residues, which comprises the following steps: S1, sulfur dissolving separation: placing the firework and firecracker waste residues in a sulfur dissolving agent, and carrying out hot filtration separation to obtain a sulfur-containing clear liquid and desulfurized residues; cooling and separating out the sulfur-containing clear liquid, and carrying out solid-liquid separation to obtain sulfur and a sulfur dissolving liquid; s2, slurrying and leaching: adding the desulfurization residues into concentrated sulfuric acid to carry out slurrying reaction, dissolving magnesium and aluminum components, and carbonizing and decomposing lead fibers at the same time; s3, solid-liquid separation and flotation: diluting and cooling the material after the pulpifying reaction, and carrying out solid-liquid separation to obtain a leachate containing magnesium and aluminum ions and residues after leaching; and S4, magnesium aluminate spinel preparation: adjusting the pH value of the leachate to separate out magnesium and aluminum in a precipitation form, filtering, drying filter residues, and calcining to obtain the magnesium aluminate spinel. According to the method, sulfur, magnesium, aluminum and other resources in the waste residues can be safely and efficiently separated and recycled, meanwhile, the final residues are subjected to harmlessness, the amount and volume of the residues are greatly reduced, and the method is suitable for industrial-scale continuous production.
Owner:CHANGSHA YANDUN RECYCLING TECHNOLOGY CO LTD

Method for extracellular preparation of rice bran protein-emblic leafflower fruit polysaccharide covalent graft

The invention discloses a method for extracellular preparation of a rice bran protein-emblic leafflower fruit polysaccharide covalent graft, and relates to the technical field of biology. The method comprises the following steps: mixing fresh phyllanthus emblica fruits, rice bran protein and water, carrying out extraction treatment by adopting a flash extractor under the ultrasonic-assisted action, then filtering to obtain filtrate, concentrating the filtrate to obtain a concentrated solution, then carrying out alcohol precipitation treatment to obtain a precipitate, and drying the precipitate to obtain the phyllanthus emblica extract. And freezing and drying to obtain the rice bran protein-emblic leafflower fruit polysaccharide covalent graft. According to the method, the one-step efficient extraction of the emblic leafflower fruit polysaccharide is realized by combining the maximum rotating speed shearing of the flash extractor and the ultrasonic-assisted effect, and the rice bran protein-emblic leafflower fruit polysaccharide covalent graft is formed while the polysaccharide is extracted by controlling the Maillard reaction conditions, so that the yield and the purity of the graft product are remarkably improved, and the cost is reduced. And the stability of the product structure and the maximization of the functionality are ensured.
Owner:SOUTH CHINA UNIV OF TECH +2

Lansoprazole sodium bicarbonate capsule and preparation process thereof

The invention belongs to the field of pharmaceutical preparations, and discloses a lansoprazole sodium bicarbonate capsule and a preparation process thereof, and the preparation process comprises the following steps: firstly, pressing lansoprazole and auxiliary materials into a tablet core; directly tabletting the hydroxypropyl methylcellulose phthalate, the auxiliary materials and the tablet core again to obtain an enteric-coated layer; and finally, carrying out third-time tabletting on sodium bicarbonate, auxiliary materials and the secondarily-pressed tablet core, and pressing into the micro-tablet which sequentially comprises the lansoprazole tablet core, the enteric-coated layer and the sodium bicarbonate quick-acting layer from inside to outside. According to the lansoprazole sodium bicarbonate capsule prepared through the method, after a patient takes the capsule, the sodium bicarbonate layer in the medicine disintegrates rapidly, the concentration of gastric acid is reduced rapidly, pain of the patient is reduced, then lansoprazole wrapping the enteric layer enters the intestinal tract to be released, the gastric acid releasing capacity of gastric cells is reduced, and the symptoms are treated firstly and then the root causes are treated.
Owner:SHANGHAI SINE WANXIANG PHARMA +1

Clear high-anthocyanin aronia instant freeze-dried fruit tea and preparation method thereof

PendingCN119523004AReduce the degree of oxidationDissolve fastTea substituesBiotechnologyFruit juice
The invention discloses clarified high-anthocyanin aronia instant freeze-dried fruit tea and a preparation method thereof, and relates to the technical field of food processing, the clarified high-anthocyanin aronia instant freeze-dried fruit tea comprises aronia juice, a drying aid, a color fixative, a color fixative and mixed essence, and the mass ratio of the aronia juice to the drying aid to the color fixative to the color fixative is 100: 45: 1: 1. By adopting a vacuum freeze-drying process, the obtained finished product can be directly and quickly dissolved in cold water in the dissolving process, and meanwhile, treatment such as direct heating and hot water brewing is avoided in the preparation process, so that the great loss of functional substances in the fruit tea due to high temperature is avoided; the drying process of vacuum freeze drying can reduce the oxidation degree of the fruit tea in the air in the drying process to the greatest extent, the total anthocyanin content of the instant freeze-dried fruit tea prepared by the method disclosed by the invention reaches 133.87 + / -3.33 mg C3GE / 100g, the total polyphenol content reaches up to 1622.04 + / -2.11 mg GAE / 100g, the total flavone content reaches up to 117.53 + / -4.67 mg CE / 100g, and functional substances in the aronia can be well reserved.
Owner:SHANXI LUAN SHIGEJIE ZHIHUA BIOTECHNOLOGY CO LTD